PharmAthene, Inc. (PIP) Posts Q2 Loss of 1c/Share

August 5, 2014 8:21 AM EDT

PharmAthene, Inc. (AMEX: PIP) reported Q2 EPS of ($0.01), $0.05 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $3.7 million versus the consensus estimate of $5 million.

For earnings history and earnings-related data on PharmAthene, Inc. (PIP) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings